Adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A single center, real-world study in China.

被引：0
|
作者：
Xu, Chongrui
Tu, Hai-Yan
Sun, Yueli
Li, Yang-Si
Xu, Bingfei
Wang, Binchao
Chen, Hua-Jun
Wang, Zhen
Zhou, Qing
Yang, Jinji
Yang, Qi
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Med, Guangzhou, Peoples R China
[2] LinkDoc Beijing Technol Co Ltd, Beijing, Peoples R China
[3] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21081
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study
    Zhang, Chenyang
    Shao, Jun
    Tang, Xiaolong
    Wu, Jiayang
    Li, Peiyi
    Li, Weimin
    Wang, Chengdi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [42] Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
    Shankar, Bairavi
    Zhang, Jiajia
    Naqash, Abdul Rafeh
    Forde, Patrick M.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    Ettinger, David S.
    Hann, Christine L.
    Brahmer, Julie R.
    Ricciuti, Biagio
    Owen, Dwight
    Toi, Yukihiro
    Walker, Paul
    Otterson, Gregory A.
    Patel, Sandip H.
    Sugawara, Shunichi
    Naidoo, Jarushka
    JAMA ONCOLOGY, 2020, 6 (12) : 1952 - 1956
  • [43] Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    Del Carpio Huerta, L.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Genua Trullos, I.
    Tuneu Valls, L.
    Stantonyonge Sesnic, N.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruellal, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S485 - S486
  • [44] Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Sung, Mike
    Zer, Mona
    Walia, Preet
    Khoja, Leila
    Maganti, Manjula
    Labbe, Catherine
    Shepherd, Frances A.
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2706 - 2712
  • [45] Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis
    Pretelli, G.
    Pavan, A.
    Dal Maso, A.
    Resi, M. V.
    Mulargiu, C.
    Ferro, A.
    Benetti, B.
    Lorenzi, M.
    Marinato, G. M.
    Frega, S.
    Pasello, G.
    Conte, P. F.
    Guarneri, V.
    Bonanno, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S51 - S51
  • [46] Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors
    Murata, Daiki
    Azuma, Koichi
    Matsuo, Norikazu
    Murotani, Kenta
    Matama, Goushi
    Kawahara, Akihiko
    Sasada, Tetsuro
    Tokito, Takaaki
    Hoshino, Tomoaki
    CANCER MEDICINE, 2023, 12 (19): : 19471 - 19479
  • [47] New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors
    Xuwen Lin
    Xi Chen
    Xiang Long
    Chao Zeng
    Zhihan Zhang
    Weiyi Fang
    Ping Xu
    Respiratory Research, 24
  • [48] New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors
    Lin, Xuwen
    Chen, Xi
    Long, Xiang
    Zeng, Chao
    Zhang, Zhihan
    Fang, Weiyi
    Xu, Ping
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [49] Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Zheng, Ying
    Kim, Ruth
    Yu, Ting
    Gayle, Julie A.
    Wassel, Christina L.
    Dreyfus, Jill
    Phatak, Hemant
    George, Saby
    ONCOLOGIST, 2021, 26 (11): : E2002 - E2012
  • [50] Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer
    Wang, Chengdi
    Qiao, Wenliang
    Jiang, Yuting
    Zhu, Min
    Shao, Jun
    Ren, Pengwei
    Liu, Dan
    Li, Weimin
    CANCER MEDICINE, 2019, 8 (08): : 4023 - 4031
12345